V4020 Vaccine

V4020 · Medigen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V4020 Vaccine, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study Evaluating the Safety, Tolerability, and Immunogenicity of V4020 Vaccine in Healthy Volunteers [Phase 1]

See pricing